Glenmark Pharma received final approval from USFDA for Tacrolimus capsules, which are used as immunosuppressants to prevent human immune system from rejecting liver, kidney and heart transplants.
from NDTV Profit - Latest https://ift.tt/3lkCdcp
from NDTV Profit - Latest https://ift.tt/3lkCdcp
Glenmark Pharma Gets Nod For Tacrolimus Capsules; Stock Gains Nearly 2%
![Glenmark Pharma Gets Nod For Tacrolimus Capsules; Stock Gains Nearly 2%]()
Reviewed by placements page
on
November 10, 2020
Rating:
No comments: